Status:
COMPLETED
Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea
Lead Sponsor:
Central Jutland Regional Hospital
Collaborating Sponsors:
Nielsen, Jens OD, M.D.
Conditions:
Nausea
Vomiting
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia concerning post- operative nausea and vomiting.
Detailed Description
Propofol and sevoflurane anaesthesia are used world wide at the anaesthetists discretion. Propofol is superior to inhalational anaesthetics as anaesthesia for patients at risk of post operative nause...
Eligibility Criteria
Inclusion
- Females younger than 50 years
- ASA I-II
- Scheduled to gynaecological laparotomies or laparoscopies
Exclusion
- Medication known to act anti-emetic
- ASA status greater than II
- Malignant hyperthermia
- Allergy to the drugs used.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00452855
Start Date
January 1 2002
End Date
May 1 2005
Last Update
March 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Viborg Hospital
Viborg, Denmark, 8800